Treatment and outcomes in anti-HMG-CoA reductase-associated immune-mediated necrotising myopathy. Comparative analysis of a single-centre cohort and published data.
Clin Exp Rheumatol
; 40(2): 320-328, 2022 Feb.
Article
en En
| MEDLINE
| ID: mdl-35225222
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Enfermedades Autoinmunes
/
Inhibidores de Hidroximetilglutaril-CoA Reductasas
/
Enfermedades Musculares
/
Miositis
Tipo de estudio:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Clin Exp Rheumatol
Año:
2022
Tipo del documento:
Article
País de afiliación:
Alemania